A recent narrative review looks at the most effective and emerging options for diagnosing and treating basal cell carcinoma.

With the COVID-19 pandemic, many of us are outdoors now more than ever. Take precautions to avoid basal cell carcinoma — and learn how to spot it. Basal cell carcinoma strikes the basal cells in our ...

The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers ...

The FDA’s decision is based on data from the ONWARDS Phase IIIa clinical programme involving nearly 2,680 adults.

Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers. * Dexcom Smart Basal is FDA cleared and now the ...

SUPER-1 evaluated GZR4 in insulin-naïve Chinese adults with T2DM, while SUPER-2 assessed those previously treated with basal insulin.

The telltale sign of this disorder is the appearance of basal cell carcinoma (BCC) after you enter puberty. Basal cell carcinoma is the most common type of skin cancer in the world. Most often found ...

Basal cell cancer is the most common form of skin cancer diagnosed in the United States. Basal cells are small, round skin cells normally found in the upper part of your skin. When these cells become ...

Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications ...

Jason C. Baker, M.D., is assistant professor of clinical medicine and attending endocrinologist at New York-Presbyterian/Weill Cornell Medical Center in New York, New York. He earned his medical ...